Skip to main content
Clinical Trials/ITMCTR1900002590
ITMCTR1900002590
Recruiting
未知

Demonstration research on platform construction of intervention of phlegm and blood stasis by TCM internal and external treatment

The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine0 sitesTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • Non\-spleen deficiency turbid non\-hyperlipidemia group inclusion criteria:
  • 1\. Non\-dyslipidemia: Adult fasting 12 hours serum TC \< 5\.2mmol/L (200mg/dl), TG \<1\.7mmol/L (150mg/dl), LDL\-C \<3\.4mmol/L (130mg/dl), HDL\-C\>1\.0 mmol/L (40 mg/dl);
  • 2\. TCM diagnosis did not reach the diagnostic criteria for spleen deficiency, phlegm and spleen deficiency syndrome;
  • 3\. Aged 18 to 75 years old;
  • 4\. Volunteer to participate in the trial and sign the informed consent form.
  • Dyslipidemia patients enrolled in the standard1 Western medicine meets the diagnostic criteria for dyslipidemia:
  • 1\. Adult fasting 12 hours serum TC \>\=5\.2mmol/L (200mg/dl) or TG \>\=1\.7mmol/L (150mg/dl), or LDL\-C \>\=3\.4 mmol/L (130mg / dl Or HDL\-C \<1\.0 mmol/L (40 mg/dl). TC is a mandatory item;
  • 2\. medical history for more than three months;
  • 3\. Chinese medicine meets the diagnostic criteria of spleen\-qi deficiency syndrome or spleen deficiency and phlegm syndrome;
  • 4\. Aged 18 to 75 years old;

Exclusion Criteria

  • 1\. Subjects with acute myocardial infarction, cerebrovascular accident, severe trauma or major surgery within six months;
  • 2\. Secondary hyperlipidemia: Hyperlipidemia caused by nephrotic syndrome, hypothyroidism, gout, acute or chronic hepatobiliary diseases, and diabetes;
  • 3\. Family hereditary dyslipidemia;
  • 4\. Hyperlipidemia caused by drugs (phenothiazines, beta\-blockers, adrenocortical steroids and certain contraceptives, etc.);
  • 5\. Heparin, thyroxine therapeutics, and other subjects who are affecting lipid metabolism drugs are being used;
  • 6\. Take antibiotics within 2 months before sampling, take microbial live bacteria preparations (including yogurt) within 1 week before sampling, and take statin lipid\-lowering drugs 2 weeks before sampling;
  • 7\. Consolidation of subjects with severe primary diseases such as liver, kidney, and hematopoietic system.

Outcomes

Primary Outcomes

Not specified

Similar Trials